GOTERM_BP_DIRECT |
GO:0022617∼extracellular matrix disassembly |
6.35E-10 |
MMP12, MMP11, MMP13, LAMB3, MMP1, MMP3, SPP1, LAMC2, MMP10 |
GOTERM_BP_DIRECT |
GO:0030574∼collagen catabolic process |
2.01E-07 |
MMP12, MMP11, MMP13, MMP1, MMP3, COL10A1, MMP10 |
GOTERM_BP_DIRECT |
GO:0008284∼positive regulation of cell proliferation |
1.48E-05 |
CXCL10, TFAP2B, EDN3, ODC1, ID4, KIF14, LAMC2, PTHLH, SOX4, HOXC10, CDC25B |
GOTERM_BP_DIRECT |
GO:0030198∼extracellular matrix organization |
1.29E-04 |
LAMB3, LOX, COL14A1, MFAP2, SPP1, COL10A1, LAMC2 |
GOTERM_BP_DIRECT |
GO:0001501∼skeletal system development |
2.16E-04 |
HOXA10, SHOX2, COL10A1, PTHLH, SOX4, HOXC10 |
GOTERM_BP_DIRECT |
GO:0032467∼positive regulation of cytokinesis |
4.28E-04 |
KIF14, CDC6, ECT2, CDC25B |
GOTERM_BP_DIRECT |
GO:0030199∼collagen fibril organization |
5.01E-04 |
MMP11, LOX, COL14A1, SERPINH1 |
GOTERM_BP_DIRECT |
GO:0008285∼negative regulation of cell proliferation |
9.90E-04 |
TFAP2B, CXCL8, IGFBP3, CXCL1, CDC6, PTHLH, SOX4, CDKN3 |
GOTERM_BP_DIRECT |
GO:0032461∼positive regulation of protein oligomerization |
0.001384 |
MMP1, MMP3, BID |
GOTERM_BP_DIRECT |
GO:0006935∼chemotaxis |
0.001428 |
CXCL10, CXCL8, PLAU, CCL20, CXCL1 |
GOTERM_BP_DIRECT |
GO:0070098∼chemokine-mediated signaling pathway |
0.002859 |
CXCL10, CXCL8, CCL20, CXCL1 |
GOTERM_BP_DIRECT |
GO:0007275∼multicellular organism development |
0.004632 |
HOXA10, MMP11, ANO1, HLF, EDN3, HMGA2, EMP1, HOXB7 |
GOTERM_BP_DIRECT |
GO:0008544∼epidermis development |
0.004749 |
LAMB3, EMP1, LAMC2, PTHLH |
GOTERM_BP_DIRECT |
GO:0043065∼positive regulation of apoptotic process |
0.006892 |
TOP2A, IGFBP3, HMGA2, ECT2, BID, SOX4 |
GOTERM_BP_DIRECT |
GO:0042769∼DNA damage response, detection of DNA damage |
0.009053 |
HMGA2, DTL, SOX4 |
GOTERM_BP_DIRECT |
GO:0006508∼proteolysis |
0.014588 |
MMP12, MMP11, MMP13, PLAU, MMP1, MMP3, MMP10 |
GOTERM_BP_DIRECT |
GO:0045944∼positive regulation of transcription from RNA polymerase II promoter |
0.015501 |
TOP2A, HOXA10, CXCL10, TFAP2B, HLF, ATAD2, SHOX2, ID4, HMGA2, SOX4 |
GOTERM_BP_DIRECT |
GO:0097070∼ductus arteriosus closure |
0.019794 |
TFAP2B, HPGD |
GOTERM_BP_DIRECT |
GO:0042035∼regulation of cytokine biosynthetic process |
0.027603 |
IGF2BP3, IGF2BP2 |
GOTERM_BP_DIRECT |
GO:0060326∼cell chemotaxis |
0.02776 |
CXCL10, CCL20, CXCL1 |
GOTERM_BP_DIRECT |
GO:0030593∼neutrophil chemotaxis |
0.028555 |
CXCL8, EDN3, CCL20 |
GOTERM_BP_DIRECT |
GO:0043154∼negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
0.030994 |
TFAP2B, LAMP3, IFI6 |
GOTERM_BP_DIRECT |
GO:0045444∼fat cell differentiation |
0.03437 |
TFAP2B, ID4, HMGA2 |
GOTERM_BP_DIRECT |
GO:0032330∼regulation of chondrocyte differentiation |
0.03535 |
SHOX2, PTHLH |
GOTERM_BP_DIRECT |
GO:0030071∼regulation of mitotic metaphase/anaphase transition |
0.03535 |
UBE2C, CDC6 |
GOTERM_BP_DIRECT |
GO:0042127∼regulation of cell proliferation |
0.037708 |
CXCL10, TFRC, PLAU, BID |
GOTERM_BP_DIRECT |
GO:2000406∼positive regulation of T cell migration |
0.039201 |
CXCL10, CCL20 |
GOTERM_BP_DIRECT |
GO:0001558∼regulation of cell growth |
0.040602 |
TFRC, IGFBP3, KIF14 |
GOTERM_BP_DIRECT |
GO:0009952∼anterior/posterior pattern specification |
0.040602 |
HOXA10, HOXB7, HOXC10 |
GOTERM_BP_DIRECT |
GO:0043085∼positive regulation of catalytic activity |
0.041525 |
IGFBP3, APOC1, CXCL1 |
GOTERM_BP_DIRECT |
GO:0031581∼hemidesmosome assembly |
0.046858 |
LAMB3, LAMC2 |
GOTERM_BP_DIRECT |
GO:0021846∼cell proliferation in forebrain |
0.046858 |
KIF14, HMGA2 |
GOTERM_CC_DIRECT |
GO:0005576∼extracellular region |
5.78E-09 |
CXCL8, LAMB3, EDN3, TFRC, COL14A1, MMP1, CCL20, IGFBP3, MMP3, ISG15, CXCL1, LAMC2, PTHLH, MMP10, MMP12, MMP11, CXCL10, MMP13, LOX, PLAU, MFAP2, APOC1, SPP1, COL10A1 |
GOTERM_CC_DIRECT |
GO:0005578∼proteinaceous extracellular matrix |
6.07E-06 |
MMP12, MMP11, MMP13, LOX, MMP1, COL14A1, MMP3, COL10A1, MMP10 |
GOTERM_CC_DIRECT |
GO:0005615∼extracellular space |
2.21E-05 |
CXCL8, EDN3, TFRC, COL14A1, CCL20, IGFBP3, MMP3, CXCL1, LAMC2, PTHLH, MMP10, CXCL10, MMP13, LOX, PLAU, SERPINH1, SPP1 |
GOTERM_CC_DIRECT |
GO:0005581∼collagen trimer |
2.22E-05 |
MMP13, LOX, MMP1, COL14A1, SERPINH1, COL10A1 |
GOTERM_CC_DIRECT |
GO:0048471∼perinuclear region of cytoplasm |
0.007649 |
TFRC, LAMP3, ODC1, SPP1, COBL, SORBS2, LAMC2, CDKN3 |
GOTERM_CC_DIRECT |
GO:0031012∼extracellular matrix |
0.023505 |
MMP11, MMP13, MMP1, COL14A1, MMP10 |
GOTERM_CC_DIRECT |
GO:0005654∼nucleoplasm |
0.042373 |
GINS1, TOP2A, HPGD, UBE2C, HSPB8, ATAD2, HMGA2, ISG15, CDC6, PTHLH, HOXC10, CDC25B, RBP1, MAGEA11, HOXB7, DTL, SOX4 |
GOTERM_MF_DIRECT |
GO:0004222∼metalloendopeptidase activity |
8.53E-05 |
MMP12, MMP11, MMP13, MMP1, MMP3, MMP10 |
GOTERM_MF_DIRECT |
GO:0004252∼serine-type endopeptidase activity |
5.17E-04 |
MMP12, MMP11, MMP13, PLAU, MMP1, MMP3, MMP10 |
GOTERM_MF_DIRECT |
GO:0008009∼chemokine activity |
9.66E-04 |
CXCL10, CXCL8, CCL20, CXCL1 |
GOTERM_MF_DIRECT |
GO:0001077∼transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
0.014362 |
HOXA10, TFAP2B, HLF, HMGA2, SOX4 |
GOTERM_MF_DIRECT |
GO:0004175∼endopeptidase activity |
0.019447 |
MMP12, MMP1, MMP3 |
GOTERM_MF_DIRECT |
GO:0045182∼translation regulator activity |
0.023582 |
IGF2BP3, IGF2BP2 |
GOTERM_MF_DIRECT |
GO:0005518∼collagen binding |
0.023691 |
MMP13, COL14A1, SERPINH1 |
GOTERM_MF_DIRECT |
GO:0048027∼mRNA 5'-UTR binding |
0.035167 |
IGF2BP3, IGF2BP2 |
KEGG_PATHWAY |
hsa05202: Transcriptional misregulation in cancer |
5.57E-06 |
HOXA10, CXCL8, HPGD, PLAU, IGFBP3, MMP3, HMGA2, MLF1 |
KEGG_PATHWAY |
hsa05323: Rheumatoid arthritis |
0.0064 |
CXCL8, MMP1, CCL20, MMP3 |
KEGG_PATHWAY |
hsa04668: TNF signaling pathway |
0.01095 |
CXCL10, CCL20, MMP3, CXCL1 |
KEGG_PATHWAY |
hsa04622: RIG-I-like receptor signaling pathway |
0.036968 |
CXCL10, CXCL8, ISG15 |
KEGG_PATHWAY |
hsa04062: Chemokine signaling pathway |
0.046265 |
CXCL10, CXCL8, CCL20, CXCL1 |